BAFF knockout improves systemic inflammation via regulating adipose tissue distribution in high-fat diet-induced obesity

Experimental and Molecular Medicine

Volumn 47, Issue 1, 2015, Pages

  Kim, Do Hwan ^a   Do, Myoung Sool ^a  

^a Handong University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A SYNTHETASE; ARGINASE 1; B CELL ACTIVATING FACTOR; CD163 ANTIGEN; CD86 ANTIGEN; CYCLOOXYGENASE 2; DIACYLGLYCEROL ACYLTRANSFERASE; FATTY ACID SYNTHASE; HAPTOGLOBIN; INTERLEUKIN 6; LECTIN; LEPTIN; LIPOPROTEIN LIPASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PERILIPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN CLEC10A; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCLASSIFIED DRUG; CONDITIONED MEDIUM; TNFSF13B PROTEIN, MOUSE;

3T3 CELL LINE; ABDOMINAL FAT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT DISTRIBUTION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDIDYMIS FAT; FAT MASS; GENE EXPRESSION REGULATION; INFLAMMATION; KNOCKOUT MOUSE; LIPID DIET; LIPOGENESIS; MACROPHAGE ACTIVATION; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PROTEIN DEPLETION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT; TISSUE SPECIFICITY; WEIGHT GAIN; ADIPOCYTE; ANIMAL; CELL CULTURE; CONDITIONED MEDIUM; DISEASE MODEL; DRUG EFFECTS; GENE INACTIVATION; GENETICS; MACROPHAGE; METABOLISM; PHARMACOLOGY;

MUS;

3T3-L1 CELLS; ADIPOCYTES; ADIPOSITY; ANIMALS; B-CELL ACTIVATING FACTOR; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; GENE KNOCKOUT TECHNIQUES; INFLAMMATION; LIPOGENESIS; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; OBESITY;

EID: 84928045662     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2014.98     Document Type: Article

References (38)

1. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-591.
2. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005;111:1448-1454.
3. Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2004;89:2595-2600.
4. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911-919.
5. Wisse BE. The in flammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004;15:2792-2800.
6. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004;92:347-355.
7. Matarese G, Moschos S, Mantzoros CS. Leptin in Immunology. J Immunol 2005;174:3137-3142.
8. Stofkova A. Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocr Regul 2009;43:157-168.
9. Muredach PR, Michael L, Megan LW, Anand R, Mitchell AL, Daniel JR. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005;111:932-939.
10. Stefan L, Sonja H, Daniela L, Susanne F, Stefan M, Franz-Georg H et al. Identification and validation of novel adipokines released from primary human adipocytes. Mol Cell Proteom 2012;11:01504-01513.
11. Tan BK, Adya R, Farhatullah S, Lewandowski KC, O'Hare P, Lehnert H et al. Omentin-1, a Novel Adipokine, is Decreased in Overweight Insulin-Resistant Women with Polycystic Ovary Syndrome: Ex Vivo and In Vivo Regulation of Omentin-1 by Insulin and Glucose. Diabetes 2008;57:801-808.
12. Kim YH, Choi BH, Cheon HG, Do MS. B cell activation factor (BAFF) is a novel adipokine that links obesity and inflammation. Exp Mol Med 2009;41:208-216.
13. Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM et al. Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome. Diabetes 2011;60:1917-1925.
14. Paul AM, Ornella B, Amy O, Krystyna P, David WL, Ping F et al. BLyS: Member of the Tumor Necrosis Factor Family and B Lymphocyte Stimulator. Science 1999;285:260-263.
15. Pascal S, Fabienne M, Véronique S, Kay H, Jean-Luc B, Nils H et al. BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth. JEM 1999;189:1747-1756.
16. Craxton A, Magaletti D, Ryan EJ, Clark EA. Macrophage- and dendritic cell99).endent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 2003;101:4464-4471.
17. Bernardetta N, Ornella B, Viktor R, Paul AM, Henrik SO, Thi SM et al. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 2001;97:198-204.
18. Michael K, Teresa GC, Fang Q, Ann BS, Colleen M, Kathy S et al. Crystal structure of extracellular human BAFF, a TNF family member that stimulates B lymphocytes. J Mol Biol 2002;315:1145-1154.
19. Vassilia-Ismini A, George N, Vassiliki P, Marilena K, Maria V, Panayiotis T et al. Adipocytes as Immune Cells: Differential Expression of TWEAK, BAFF, and APRIL and Their Receptors (Fn14, BAFF-R, TACI, and BCMA) at Different Stages of Normal and Pathological Adipose Tissue Development. J Immunol 2009;183:5948-5956.
20. Gras MP, Laâbi Y, Linares-Cruz G, Blondel MO, Rigaut JP, Brouet JC et al. BCMAp: an integral membrane protein in the Golgi apparatus of human mature B lymphocytes. Int Immunol. 1995;7:1093-1106.
21. Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol 2009;9:491-502.
22. Do MS, Jeong HS, Choi BH, Hunter L, Langley S, Pazmany L et al. Inflammatory gene expression patterns revealed by DNA microarray analysis in TNF-α-treated SGBS human adipocytes. Yonsei Med J 2006;47:729-736.
23. Wabitsch M, Brenner RE, Melzner I, Braun M, Moller P, Heinze E et al. Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obes Relat Metab Disord 2001;25:8-15.
24. Fischer-Posovszky P, Newell FS, Wabitsch M, Tornqvist HE. Human SGBS cells-a unique tool for studies of human fat cell biology. Obes Facts 2008;1:184-189.
25. Kim MY, Kim DH, Do MS. B-cell-activating factor is a regulator of adipokines and a possible mediator between adipocytes and macrophages. Exp Mol Med 2013;45:e4.
26. Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008;29:2959-2971.
27. Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P et al. Mice transgenic for Baff develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 1999;190:1697-1710.
28. Sage AP, Tsiantoulas D, Baker L, Harrison J, Masters L, Murphy D et al. BAFF receptor deficiency reduces the development of atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2012;32:1573-1576.
29. Kyaw T, Cui P, Tay C, Kanellakis P, Hosseini H, Liu E et al. BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE (-/-) mice. PLoS One 2013;8:e60430.
30. Hamada M, Abe M, Miyake T, Kawasaki K, Tada F, Furukawa S et al. B cell-activating factor controls the production of adipokines and induces insulin resistance. Obesity 2011;19:1915-1922.
31. Tada F, Abe M, Kawasaki K, Miyake T, Shiyi C, Hiasa Y et al. B cell activating factor in obesity is regulated by oxidative stress in adipocytes. J Clin Biochem Nutr 2013;52:120-127.
32. Kawasaki K, Abe M, Tada F, Tokumoto Y, Chen S, Miyake T et al. Blockade of B-cell-activating factor signaling enhances hepatic steatosis induced by a high-fat diet and improves insulin sensitivity. Lab Invest 2013;93:311-321.
33. Liping Q, Brice K, Jerome S, Jianhua S. Adiponectin inhibits lipolysis in mouse adipocytes. Diabetes 2011;60:1519-1527.
34. Patrizia S, Yongmei H, Ching-Liang C, Thi-Sau M, Anthony LD, Marco AC et al. Myeloid cells, BAFF, and IFN-γ establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice. J Exp Med 2010;207:1757-1773.
35. Yan Z, Stefania G, John PG, Jane AG, Marc M. A role for B cell-activating factor of the TNF family in chemically induced autoimmunity. J Immunol 2005;175:6163-6168.
36. Tran TT, Yamamoto Y, Gesta S, Kahn CR. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 2008;7:410-420.
37. Samantha LH, Lindsay EW, Michael G, Donald JC, David EJ. Intrinsic depot-specific differences in the secretome of adipose tissue, preadipocytes, and adipose tissuedipose tissue, and adipose tissue. Diabetes 2010;59:3008-3016.
38. Mackay F, Pascal S. Cracking the BAFF code. Nat Rev Immunol 2009;9:491-502.